1 Market Overview
1.1 Neuroprotective Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuroprotective Agents Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cerebrovascular Diseases
1.2.3 Neurodegenerative Disorders
1.2.4 Ophthalmic Diseases
1.2.5 Traumatic CNS Injuries
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuroprotective Agents Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Neuroprotective Agents Market Size & Forecast
1.4.1 Global Neuroprotective Agents Sales in Value (2016-2026))
1.4.2 Global Neuroprotective Agents Sales in Volume (2016-2026)
1.4.3 Global Neuroprotective Agents Price by Type (2016-2026) & (USD/MT)
1.5 Global Neuroprotective Agents Production Capacity Analysis
1.5.1 Global Neuroprotective Agents Total Production Capacity (2016-2026)
1.5.2 Global Neuroprotective Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neuroprotective Agents Market Drivers
1.6.2 Neuroprotective Agents Market Restraints
1.6.3 Neuroprotective Agents Trends Analysis
2 Manufacturers Profiles
2.1 Genervon Biopharmaceuticals
2.1.1 Genervon Biopharmaceuticals Details
2.1.2 Genervon Biopharmaceuticals Major Business
2.1.3 Genervon Biopharmaceuticals Neuroprotective Agents Product and Services
2.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 NeuroVive Pharmaceutical
2.2.1 NeuroVive Pharmaceutical Details
2.2.2 NeuroVive Pharmaceutical Major Business
2.2.3 NeuroVive Pharmaceutical Neuroprotective Agents Product and Services
2.2.4 NeuroVive Pharmaceutical Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Ceregene
2.3.1 Ceregene Details
2.3.2 Ceregene Major Business
2.3.3 Ceregene Neuroprotective Agents Product and Services
2.3.4 Ceregene Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Neuren Pharmaceuticals
2.4.1 Neuren Pharmaceuticals Details
2.4.2 Neuren Pharmaceuticals Major Business
2.4.3 Neuren Pharmaceuticals Neuroprotective Agents Product and Services
2.4.4 Neuren Pharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Allon Therapeutics
2.5.1 Allon Therapeutics Details
2.5.2 Allon Therapeutics Major Business
2.5.3 Allon Therapeutics Neuroprotective Agents Product and Services
2.5.4 Allon Therapeutics Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Neuroprotective Agents Sales by Manufacturer
3.1 Global Neuroprotective Agents Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Neuroprotective Agents Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Neuroprotective Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Neuroprotective Agents Manufacturer Market Share
3.4.2 Top 6 Neuroprotective Agents Manufacturer Market Share
3.5 Global Neuroprotective Agents Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Neuroprotective Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neuroprotective Agents Market Size by Region
4.1.1 Global Neuroprotective Agents Sales in Volume by Region (2016-2026)
4.1.2 Global Neuroprotective Agents Revenue by Region (2016-2026)
4.2 North America Neuroprotective Agents Revenue (2016-2026)
4.3 Europe Neuroprotective Agents Revenue (2016-2026)
4.4 Asia-Pacific Neuroprotective Agents Revenue (2016-2026)
4.5 South America Neuroprotective Agents Revenue (2016-2026)
4.6 Middle East and Africa Neuroprotective Agents Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Neuroprotective Agents Sales in Volume by Type (2016-2026)
5.2 Global Neuroprotective Agents Revenue by Type (2016-2026)
5.3 Global Neuroprotective Agents Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Neuroprotective Agents Sales in Volume by Application (2016-2026)
6.2 Global Neuroprotective Agents Revenue by Application (2016-2026)
6.3 Global Neuroprotective Agents Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Neuroprotective Agents Sales by Type (2016-2026)
7.2 North America Neuroprotective Agents Sales by Application (2016-2026)
7.3 North America Neuroprotective Agents Market Size by Country
7.3.1 North America Neuroprotective Agents Sales in Volume by Country (2016-2026)
7.3.2 North America Neuroprotective Agents Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Neuroprotective Agents Sales by Type (2016-2026)
8.2 Europe Neuroprotective Agents Sales by Application (2016-2026)
8.3 Europe Neuroprotective Agents Market Size by Country
8.3.1 Europe Neuroprotective Agents Sales in Volume by Country (2016-2026)
8.3.2 Europe Neuroprotective Agents Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Neuroprotective Agents Sales by Type (2016-2026)
9.2 Asia-Pacific Neuroprotective Agents Sales by Application (2016-2026)
9.3 Asia-Pacific Neuroprotective Agents Market Size by Region
9.3.1 Asia-Pacific Neuroprotective Agents Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Neuroprotective Agents Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Neuroprotective Agents Sales by Type (2016-2026)
10.2 South America Neuroprotective Agents Sales by Application (2016-2026)
10.3 South America Neuroprotective Agents Market Size by Country
10.3.1 South America Neuroprotective Agents Sales in Volume by Country (2016-2026)
10.3.2 South America Neuroprotective Agents Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neuroprotective Agents Sales by Type (2016-2026)
11.2 Middle East & Africa Neuroprotective Agents Sales by Application (2016-2026)
11.3 Middle East & Africa Neuroprotective Agents Market Size by Country
11.3.1 Middle East & Africa Neuroprotective Agents Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Neuroprotective Agents Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Neuroprotective Agents Typical Distributors
12.3 Neuroprotective Agents Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
【掲載企業】
Genervon Biopharmaceuticals、NeuroVive Pharmaceutical、Ceregene、Neuren Pharmaceuticals、Allon Therapeutics
【免責事項】
https://www.globalresearch.jp/disclaimer